Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

8:30am - 9:30am 60 mins
9:30am - 10:00am 30 mins
Microbiome Therapeutics US
Transforming the Therapeutic Landscape of Microbiome outside of the gut (Asthma, Neuro, Cancer, Respiratory, Autoimmune Diseases)
  • David Donabedian, PhD - CEO, Co-Founder, Axial Biotherapeutics
  • Understand the application of gut-brain and gut liver axis
  • Hear clinical data on impact of gut microbiome/nutrition & depression
10:00am - 10:30am 30 mins
Microbiome Therapeutics US
Biological, Chemical, and Spatial Drivers of Microbiota Structure and Function: Therapeutic Implications
  • Elliott Friedman - Senior Research Investigator, PennCHOP Microbiome Program
  • Explore issues companies launching live biotherapeutic products, regardless of the indication
10:30am - 11:00am 30 mins
Microbiome Therapeutics US
Coffee and Networking Break
11:00am - 11:30am 30 mins
Microbiome Therapeutics US
The impact of Hospitals and Universities: Academia, labs
  • Beth McCormick - Founder, Center for Microbiome Research
  • How are universities affecting microbiome studies
  • How are studies being funded and what is receiving the most attention
  • What level of involvement comes from biotech companies?
11:30am - 12:30pm 60 mins
Microbiome Therapeutics US
Keynote: The Science, Business and Growth of the Microbiome Frontier
  • Lee Jones - Founder, President and CEO, Rebiotix, USA
12:30pm - 1:30pm 60 mins
Microbiome Therapeutics US
Lunch and Networking
1:30pm - 2:00pm 30 mins
Microbiome Therapeutics US
Adapting Emerging Technologies and Applications Towards the Future
  • Rodolphe Clerval - CBO, Enterome
  • How do you know which new technology is going to provide the necessary data?
  • Applying platforms toward microbiome therapeutic areas
2:00pm - 2:30pm 30 mins
Microbiome Therapeutics US
Standardizing Microbiomics: Collection, Purification and Analysis
  • Raul Cano - CSO, The BioCollective
  • Methods and new technologies for sample collection and standardization
  • Sequencing method development
  • Metagenomic data analysis
  • Tissue engineering
2:30pm - 3:00pm 30 mins
Microbiome Therapeutics US
Unleashing the power of microbiome with AI, Synthetic Biology, and Beyond
  • Chengwei Luo - CEO, DeepBiome Therapeutics
  • Discovering microbiome-human interfaces via AI and data engineering
  • Scaling global microbiome effort by synthetic biology
  • Future challenges
3:00pm - 3:30pm 30 mins
Microbiome Therapeutics US
Showcase Spotlight: Platform Case study
3:30pm - 4:00pm 30 mins
Microbiome Therapeutics US
Networking Coffee Break
4:00pm - 5:00pm 60 mins
Microbiome Therapeutics US
The Oral Microbiome Gateway to Systemic Health – Easily Accessible Yet Underappreciated
  • Bonnie Feldman - Healthcare Corporate Development Consulting, DrBonnie360, USA

The oral microbiome is a galactic microcosm that is both a gateway and a mirror to the rest of the human body. Comprised of over 700 prevalent taxa at the species level with distinct subsets predominating in different habitats, the oral cavity is residence to diverse communities of bacteria, fungi, and viruses.

Balance and imbalance between microbial communities can influence the body’s state of health and disease, including heart and lung disease, cancer and various autoimmune diseases. As advances in big data analytics, next generation sequencing, and systems immunology fuel our understanding of the human microbiome, our approach toward oral health and systemic immunity simultaneously evolve.

With incidence of chronic disease on the rise, this talk will explore the latest research on the oral microbiome as a reservoir for disease pathogenesis and also a target for therapeutic intervention.

5:00pm - 6:00pm 60 mins
Microbiome Networking Reception